SEZARY SYNDROME
Clinical trials for SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody targets Hard-to-Treat skin cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new drug, DT-7012, for people with advanced cutaneous T-cell lymphoma (CTCL) that has not responded to other treatments. The drug is an antibody designed to seek out and destroy cancer cells in the skin while also helping the immune system fight the…
Matched conditions: SEZARY SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 02:40 UTC
-
New hope for Hard-to-Treat skin cancer: safer chemo combo enters trials
Disease control Not yet recruitingThis study tests a new combination of drugs (aclarubicin plus cyclophosphamide, vincristine, and prednisone, called CAOP) in 37 people aged 60+ with relapsed or refractory cutaneous T-cell lymphoma (CTCL), a rare skin cancer. The goal is to find the safest dose and see if it shri…
Matched conditions: SEZARY SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Rare skin disease may raise lymphoma risk – scientists investigate
Knowledge-focused Not yet recruitingThis study looks at 10 adults with a rare genetic skin condition called NIPAL4 ichthyosis. Researchers want to understand why three patients with this condition also developed a rare lymphoma (Sezary syndrome). They will analyze blood immune cells to see if there is a pattern tha…
Matched conditions: SEZARY SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC